NCT05561686 2022-09-30Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast CancerHunan Cancer HospitalUnknown100 enrolled
NCT05429294 2022-06-23Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038First Affiliated Hospital Xi'an Jiaotong UniversityPhase 2 Unknown209 enrolled